Recent progress in non-invasive prenatal diagnosis

Seminars in Fetal and Neonatal Medicine

Volumn 13, Issue 2, 2008, Pages 57-62

  Hahn, Sinuhe ^a   Zhong, Xiao Yan ^a   Holzgreve, Wolfgang ^a  

^a UNIVERSITY WOMEN S HOSPITAL   (Switzerland)

Author keywords

Cell free fetal DNA mRNA; Down syndrome; Fetal cells; Maternal blood; Non invasive; Prenatal diagnosis

Indexed keywords

MASPIN;

ANEUPLOIDY; ARTICLE; CYSTIC FIBROSIS; DOWN SYNDROME; EPIGENETICS; FETUS CELL; FETUS WASTAGE; FLUORESCENCE IN SITU HYBRIDIZATION; GENE LOCUS; GENETIC TRAIT; HUMAN; KARYOTYPING; POLYMERASE CHAIN REACTION; PRENATAL DIAGNOSIS; SINGLE NUCLEOTIDE POLYMORPHISM; THALASSEMIA; TRISOMY;

ANEUPLOIDY; DNA; DOWN SYNDROME; FEMALE; FETAL DISEASES; FETUS; GENETIC DISEASES, INBORN; HUMANS; MATERNAL-FETAL EXCHANGE; PREGNANCY; PRENATAL DIAGNOSIS; RNA;

EID: 38949184249     PISSN: 1744165X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.siny.2007.11.001     Document Type: Article

References (25)

1. Hahn S., and Holzgreve W. Prenatal diagnosis using fetal cells and cell-free fetal DNA in maternal blood: what is currently feasible?. Clin Obstet Gynecol 45 (2002) 649-656
2. Bianchi D.W., Avent N.D., Costa J.M., and van der Schoot C.E. Noninvasive prenatal diagnosis of fetal Rhesus D: ready for Prime(r) Time. Obstet Gynecol 106 (2005) 841-844
3. Chiu R.W., and Lo Y.M. The biology and diagnostic applications of fetal DNA and RNA in maternal plasma. Curr Top Dev Biol 61 (2004) 81-111
4. Bianchi D.W., Simpson J.L., Jackson L.G., et al. Fetal gender and aneuploidy detection using fetal cells in maternal blood: analysis of NIFTY I data. National Institute of Child Health and Development Fetal Cell Isolation Study. Prenat Diagn 22 (2002) 609-615
5. Hahn S., Sant R., and Holzgreve W. Fetal cells in maternal blood: current and future perspectives. Mol Hum Reprod 4 (1998) 515-521
6. Troeger C., Zhong X.Y., Burgemeister R., et al. Approximately half of the erythroblasts in maternal blood are of fetal origin. Mol Hum Reprod 5 (1999) 1162-1165
7. Cheung M.C., Goldberg J.D., and Kan Y.W. Prenatal diagnosis of sickle cell anaemia and thalassaemia by analysis of fetal cells in maternal blood. Nat Genet 14 (1996) 264-268
8. Di N.E., Ghezzi F., Vitucci A., et al. Prenatal diagnosis of beta-thalassaemia using fetal erythroblasts enriched from maternal blood by a novel gradient. Mol Hum Reprod 6 (2000) 571-574
9. Garvin A.M., Holzgreve W., and Hahn S. Highly accurate analysis of heterozygous loci by single cell PCR. Nucleic Acids Res 26 (1998) 3468-3472
10. Babochkina T., Mergenthaler S., De N.G., et al. Numerous erythroblasts in maternal blood are impervious to fluorescent in situ hybridization analysis, a feature related to a dense compact nucleus with apoptotic character. Haematologica 90 (2005) 740-745
11. Prieto B., Candenas M., Ladenson J.H., and Alvarez F.V. Comparison of different CD71 monoclonal antibodies for enrichment of fetal cells from maternal blood. Clin Chem Lab Med 40 (2002) 126-131
12. Kolialexi A., Vrettou C., Traeger-Synodinos J., et al. Noninvasive prenatal diagnosis of beta-thalassaemia using individual fetal erythroblasts isolated from maternal blood after enrichment. Prenat Diagn 27 (2007) 1228-1232
13. Coata G., Tilesi F., Fizzotti M., et al. Prenatal diagnosis of genetic abnormalities using fetal CD34+ stem cells in maternal circulation and evidence they do not affect diagnosis in later pregnancies. Stem Cells 19 (2001) 534-542
14. Guetta E., Gutstein-Abo L., and Barkai G. Trophoblasts isolated from the maternal circulation: in vitro expansion and potential application in non-invasive prenatal diagnosis. J Histochem Cytochem 53 (2005) 337-339
15. Lo Y.M., and Chiu R.W. Prenatal diagnosis: progress through plasma nucleic acids. Nat Rev Genet 8 (2007) 71-77
16. Lo Y.M., Tsui N.B., Chiu R.W., et al. Plasma placental RNA allelic ratio permits noninvasive prenatal chromosomal aneuploidy detection. Nat Med 13 (2007) 218-223
17. Lo Y.M., Lun F.M., Chan K.C., et al. Digital PCR for the molecular detection of fetal chromosomal aneuploidy. Proc Natl Acad Sci U S A 104 (2007) 13116-13121
18. Chim S.S., Tong Y.K., Chiu R.W., et al. Detection of the placental epigenetic signature of the maspin gene in maternal plasma. Proc Natl Acad Sci U S A 102 (2005) 14753-14758
19. Tong Y.K., Ding C., Chiu R.W., et al. Noninvasive prenatal detection of fetal trisomy 18 by epigenetic allelic ratio analysis in maternal plasma: theoretical and empirical considerations. Clin Chem 52 (2006) 2194-2202
20. Chan K.C., Ding C., Gerovassili A., et al. Hypermethylated RASSF1A in maternal plasma: A universal fetal DNA marker that improves the reliability of noninvasive prenatal diagnosis. Clin Chem 52 (2006) 2211-2218
21. Lo Y.M., Tein M.S., Lau T.K., et al. Quantitative analysis of fetal DNA in maternal plasma and serum: implications for noninvasive prenatal diagnosis. Am J Hum Genet 62 (1998) 768-775
22. Hahn S., and Holzgreve W. Fetal cells and cell-free fetal DNA in maternal blood: new insights into pre-eclampsia. Hum Reprod Update 8 (2002) 501-508
23. Lo Y.M., Lau T.K., Zhang J., et al. Increased fetal DNA concentrations in the plasma of pregnant women carrying fetuses with trisomy 21. Clin Chem 45 (1999) 1747-1751
24. Zhong X.Y., Burk M.R., Troeger C., Jackson L.R., Holzgreve W., and Hahn S. Fetal DNA in maternal plasma is elevated in pregnancies with aneuploid fetuses. Prenat Diagn 20 (2000) 795-798
25. Zimmermann B., El-Sheikhah A., Nicolaides K., Holzgreve W., and Hahn S. Optimized real-time quantitative PCR measurement of male fetal DNA in maternal plasma. Clin Chem 51 (2005) 1598-1604